All Stories

  1. Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments

    Article • International Clinical Psychopharmacology, March 2017, Wolters Kluwer Health

    Professor Keith A Wesnes

  2. Effects of the Red Bull energy drink on cognitive function and mood in healthy young volunteers

    Article • Journal of Psychopharmacology, February 2017, SAGE Publications

    Professor Keith A Wesnes

  3. Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials

    Article • International Journal of Geriatric Psychiatry, January 2017, Wiley

    Professor Keith A Wesnes

  4. Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2017, Elsevier

    Professor Keith A Wesnes

  5. Acute consumption of Peppermint and Chamomile teas produce contrasting effects on cognition and mood in healthy young adults

    Article • Plant Science Today, September 2016, Horizon E-Publishing Group

    Professor Keith A Wesnes, Dr Mark C Moss

  6. Relationships Among Cognitive Function and Cerebral Blood Flow, Oxidative Stress, and Inflammation in Older Heart Failure Patients

    Article • Journal of Cardiac Failure, July 2016, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  7. The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

    Article • Journal of Psychopharmacology, March 2016, SAGE Publications

    Professor Keith A Wesnes

  8. Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers

    Article • Alcoholism Clinical and Experimental Research, March 2016, Wiley

    Professor Keith A Wesnes

  9. Hearing loss and cognition in the Busselton Baby Boomer cohort: An epidemiological study

    Article • The Laryngoscope, February 2016, Wiley

    Professor Robert H Eikelboom, Professor Keith A Wesnes

  10. Differences in memory function between 5-HT1A receptor genotypes in patients with major depressive disorder

    Article • CNS Spectrums, January 2016, Cambridge University Press

    Professor Keith A Wesnes

  11. Norms for healthy adults aged 18–87 years for the Cognitive Drug Research System: An automated set of tests of attention, information processing and memory for use in clinical trials

    Article • Journal of Psychopharmacology, January 2016, SAGE Publications

    Professor Keith A Wesnes

  12. Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial

    Article • Epilepsia, January 2016, Wiley

    Professor Keith A Wesnes

  13. Corrigendum: Examining the Nootropic Effects of a Special Extract ofBacopa monnieraon Human Cognitive Functioning: 90 day Double-Blind Placebo-Controlled Randomized Trial

    Article • Phytotherapy Research, August 2015, Wiley

    Professor Keith A Wesnes

  14. Is There an Association Between Metabolic Syndrome and Cognitive Function in Very Old Adults? The Newcastle 85+ Study

    Article • Journal of the American Geriatrics Society, April 2015, Wiley

    Professor Thomas B L Kirkwood, Professor Keith A Wesnes, Dr Antoneta Granic

  15. Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefoliusL.) to healthy middle-age adults

    Article • Human Psychopharmacology Clinical and Experimental, March 2015, Wiley

    Professor Keith A Wesnes, Professor Andrew Scholey

  16. Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, March 2015, Elsevier

    Professor Keith A Wesnes

  17. Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

    Article • Multiple Sclerosis International, January 2015, Hindawi Publishing Corporation

    Professor Keith A Wesnes

  18. Hjerneødem etter status epilepticus

    Article • Tidsskrift for Den norske legeforening, January 2015, Norwegian Medical Association

    Professor Keith A Wesnes

  19. Investigating the reliability and validity of candidate psychophysiological endophenotypes of affective processing

    Article • International Journal of Psychophysiology, November 2014, Elsevier

    Professor Keith A Wesnes

  20. P.2.b.009 Effects of levomilnacipran ER on measures of attention in a phase III trial of major depressive disorder

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Professor Keith A Wesnes

  21. Moving beyond the pros and cons of automating cognitive testing in pathological aging and dementia: the case for equal opportunity

    Article • Alzheimer s Research & Therapy, August 2014, Springer Science + Business Media

    Professor Keith A Wesnes

  22. Functional Living in Older Adults With Type 2 Diabetes

    Article • Journal of Aging and Health, August 2014, SAGE Publications

    Professor Keith A Wesnes

  23. PERFORMANCE OF ADULTS WITH DOWN SYNDROME (DS) ON COGNITIVE AND BEHAVIORAL TESTS: BASELINE DATA FROM A PHASE 2A STUDY OF THE INVESTIGATIONAL AGENT ELND005 (SCYLLO-INOSITOL)

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Professor Keith A Wesnes

  24. Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis

    Article • PLoS ONE, May 2014, PLOS

    Professor Keith A Wesnes

  25. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies

    Article • International Journal of Geriatric Psychiatry, April 2014, Wiley

    Professor Keith A Wesnes

  26. Poster #T260 OBJECT PATTERN SEPARATION PERFORMANCE IN SCHIZOPHRENICS IS CONSISTENT WITH DISRUPTED HIPPOCAMPAL DENTATE GYRUS ACTIVITY AND COMPROMISED NEUROGENESIS

    Article • Schizophrenia Research, April 2014, Elsevier

    Professor Keith A Wesnes

  27. Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients

    Article • Nutrition Reviews, February 2014, Oxford University Press (OUP)

    Professor Keith A Wesnes

  28. The role of human cognitive neuroscience in drug discovery for the dementias

    Article • Current Opinion in Pharmacology, February 2014, Elsevier

    Professor Keith A Wesnes

  29. Exploring individual differences in Affective processing using psychophysiology

    Article • Frontiers in Human Neuroscience, January 2014, Frontiers

    Professor Keith A Wesnes

  30. Compromised Object Pattern Separation Performance in Parkinson′s Disease Suggests Dentate Gyrus Neurogenesis may be Compromised in the Condition

    Article • Journal of Alzheimer’s Disease & Parkinsonism, January 2014, OMICS Publishing Group

    Professor Keith A Wesnes

  31. Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

    Article • Alzheimer s Research & Therapy, January 2014, Springer Science + Business Media

    Professor Keith A Wesnes

  32. Corrigendum to “An evaluation of the cognitive and mood effects of an energy shot over a 6 h period in volunteers. A randomized, double-blind, placebo controlled, cross-over study” [Appetite 67 (2013) 105–113]

    Article • Appetite, December 2013, Elsevier

    Professor Keith A Wesnes

  33. Evaluation of drug–drug interactions of sodium oxybate with diclofenac: Results from a pharmacokinetic/pharmacodynamic study

    Article • Sleep Medicine, December 2013, Elsevier

    Professor Keith A Wesnes

  34. Evaluation of drug–drug interactions of sodium oxybate with divalproex: Results from a pharmacokinetic/pharmacodynamic study

    Article • Sleep Medicine, December 2013, Elsevier

    Professor Keith A Wesnes

  35. Weight and urinary incontinence: the missing links

    Article • International Urogynecology Journal, November 2013, Springer Science + Business Media

    Professor Keith A Wesnes

  36. P.5.b.004 Object pattern separation performance in Alzheimer's patients links compromised hippocampal neurogenesis to APOE4 status and CSF Aβ42

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Professor Keith A Wesnes

  37. P.7.d.006 Differential effects on attention over 24 weeks of an NMDA antagonist versus carbamazepine in paediatric epilepsy patients

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Professor Keith A Wesnes

  38. P.2.b.031 Differences in memory function between 5-HT1A genotypes in patients with major depressive disorder

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Professor Keith A Wesnes

  39. P.1.j.009 Breaking evidence from a human object pattern separation test of disrupted hippocampal dentate gyrus activity in schizophrenics

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Professor Keith A Wesnes

  40. Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial

    Article • PLoS ONE, September 2013, PLOS

    Professor Keith A Wesnes

  41. An evaluation of the cognitive and mood effects of an energy shot over a 6h period in volunteers. A randomized, double-blind, placebo controlled, cross-over study

    Article • Appetite, August 2013, Elsevier

    Professor Keith A Wesnes

  42. Cognitive evidence in people with Alzheimer's disease that compromised hippocampal neurogenesis is related both to APOE-ɛ4 status and CSF beta-amyloid 42

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor Keith A Wesnes

  43. Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: A double-blind, placebo-controlled multicentre trial

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor Keith A Wesnes

  44. Examining the cognitive effects of a special extract of Bacopa monniera (CDRI08: Keenmnd): A review of ten years of research at Swinburne University

    Article • Journal of Pharmacy & Pharmaceutical Sciences, June 2013, JPPS Journal

    Professor Keith A Wesnes

  45. Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial

    Article • Journal of Psychopharmacology, May 2013, SAGE Publications

    Professor Keith A Wesnes, Professor Andrew Scholey

  46. Effects of nicotine withdrawal on cognition in a clinical trial setting

    Article • Psychopharmacology, April 2013, Springer Science + Business Media

    Professor Keith A Wesnes

  47. Preventing urinary incontinence during pregnancy and postpartum: a review

    Article • International Urogynecology Journal, February 2013, Springer Science + Business Media

    Professor Keith A Wesnes

  48. Natural Substances as Treatments for Age-Related Cognitive Declines

    Article • January 2013, Taylor & Francis

    Professor Keith A Wesnes

  49. Breakfast is associated with enhanced cognitive function in schoolchildren. An internet based study

    Article • Appetite, December 2012, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  50. P.1.g.015 Is neurogenesis in the dentate gyrus compromised in Parkinson's disease?

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Professor Keith A Wesnes

  51. P.1.g.003 The effects of chronic lower back pain on cognitive function

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Professor Keith A Wesnes

  52. P.5.a.002 Validation of an internet based instrument for assessing cognitive function

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Professor Keith A Wesnes

  53. P.5.a.001 A comparison of traditional neuropsychological tests and automated cognitive tests in assessing cognitive decline in the elderly

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Professor Keith A Wesnes

  54. Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial

    Article • PLoS ONE, September 2012, PLOS

    Professor Keith A Wesnes

  55. Relationship Between Cognition, Magnetic Resonance White Matter Hyperintensities, and Cardiovascular Autonomic Changes in Late-Life Depression

    Article • American Journal of Geriatric Psychiatry, August 2012, Elsevier

    Professor Keith A Wesnes

  56. Internet-based cognitive function assessment

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Professor Keith A Wesnes

  57. Year-by-year cognitive decline in non-demented elderly aged 70 to 90 years

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Professor Keith A Wesnes

  58. The neuropsychological tests used in ADNI will not prove useful for clinical trials in preclinical Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Professor Keith A Wesnes

  59. Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial

    Article • PLoS ONE, June 2012, PLOS

    Professor Keith A Wesnes

  60. Poster #154 THE CENTRAL ROLE OF ATTENTION AND INFORMATION PROCESSING DEFICITS IN THE PROFILE OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2012, Elsevier

    Professor Keith A Wesnes

  61. Poster #155 EVALUATION OF A RULE SWITCHING TEST DESIGNED TO ASSESS EXECUTIVE CONTROL

    Article • Schizophrenia Research, April 2012, Elsevier

    Professor Keith A Wesnes

  62. The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population

    Article • Neurobiology of Aging, April 2012, Elsevier

    Professor Keith A Wesnes

  63. A randomized controlled trial investigating the effect of Pycnogenol and BacopaCDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Interventi...

    Article • Nutrition Journal, March 2012, Springer Science + Business Media

    Professor Keith A Wesnes, Professor Andrew Scholey

  64. The cognitive profile of type 1 Gaucher disease patients

    Article • Journal of Inherited Metabolic Disease, February 2012, Springer Science + Business Media

    Professor Keith A Wesnes

  65. The effect of high lactose–isomaltulose on cognitive performance of young children. A double blind cross-over design study

    Article • Appetite, February 2012, Elsevier

    Professor Keith A Wesnes

  66. Acute ingestion of different macronutrients differentially enhances aspects of memory and attention in healthy young adults

    Article • Biological Psychology, February 2012, Elsevier

    Professor Keith A Wesnes

  67. Herbal Cognitive Enhancers: New Developments and Challenges for Therapeutic Applications

    Article • January 2012, Springer Science + Business Media

    Professor Keith A Wesnes

  68. Short-Term Study on the Effects of Rosemary on Cognitive Function in an Elderly Population

    Article • Journal of Medicinal Food, January 2012, Mary Ann Liebert Inc

    Professor Keith A Wesnes, Professor Andrew Scholey

  69. Analysis of Neuron-Specific Enolase and S100B as Biomarkers of Cognitive Decline Following Surgery in Older People

    Article • Dementia and Geriatric Cognitive Disorders, January 2012, Karger Publishers

    Professor Keith A Wesnes

  70. Fastlegeordningen trenger flere leger

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Keith A Wesnes

  71. The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning

    Article • Psychopharmacology, October 2011, Springer Science + Business Media

    Professor Keith A Wesnes

  72. The scopolamine model as a pharmacodynamic marker in early drug development

    Article • Psychopharmacology, September 2011, Springer Science + Business Media

    Professor Keith A Wesnes

  73. P.5.a.002 The measurement of normal and abnormal age-related declines in human cognitive function

    Article • European Neuropsychopharmacology, September 2011, Elsevier

    Professor Keith A Wesnes

  74. Visuo-perceptual task performance in dementia with Lewy bodies

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Professor Keith A Wesnes

  75. The measurement of normal and abnormal age-related declines in human cognitive function

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Professor Keith A Wesnes

  76. Cognitive performance in relapsing remitting multiple sclerosis: A longitudinal study in daily practice using a brief computerized cognitive battery

    Article • BMC Neurology, June 2011, Springer Science + Business Media

    Professor Keith A Wesnes

  77. PND63 LITTLE OR NO TREATMENT EFFECT? APPLICATION OF GROWTH MIXTURE MODELS TO EXPLORE UNKNOWN SUBGROUPS OF DIFFERENTIAL RESPONDERS TO TREATMENT

    Article • Value in Health, May 2011, Elsevier

    Professor Keith A Wesnes

  78. PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

    Article • Value in Health, May 2011, Elsevier

    Professor Keith A Wesnes

  79. Pharmacodynamic Evaluation: CNS

    Article • January 2011, Springer Science + Business Media

    Professor Keith A Wesnes

  80. Evaluation of techniques to identify beneficial effects of nutrition and natural products on cognitive function

    Article • Nutrition Reviews, October 2010, Oxford University Press (OUP)

    Professor Keith A Wesnes

  81. Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson’s disease

    Article • Journal of Psychopharmacology, October 2010, SAGE Publications

    Professor Keith A Wesnes

  82. Does a neuropsychological index of hemispheric lateralization predict onset of upper respiratory tract infectious symptoms?

    Article • British Journal of Health Psychology, September 2010, Wiley

    Professor Keith A Wesnes

  83. P.7.c.006 Issues and opportunities in cognitive psychopharmacology trials in children

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Professor Keith A Wesnes

  84. Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness

    Article • Journal of Hypertension, August 2010, Wolters Kluwer Health

    Professor Keith A Wesnes, Professor Andrew Scholey

  85. P.1.c.037 The profile of attentional deficits in schizophrenia: implications for pharmacotherapy

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Professor Keith A Wesnes

  86. P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in healthy subjects in a scopolamine model of cognitive impairment

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Professor Keith A Wesnes

  87. Attentional deficits in the dementias: Behavioural and treatment implications

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor Keith A Wesnes

  88. Visual Object Pattern Separation: A Paradigm for Studying the Role of the Dentate Gyrus in Memory Disorders

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor Keith A Wesnes

  89. Abstract #11: The Disruptions to Cognition, Everyday Function, and Quality of Life in Oncology Patients: A Therapeutic Opportunity?

    Article • Neurotherapeutics, July 2010, Springer Science + Business Media

    Professor Keith A Wesnes

  90. Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease

    Article • Neuroscience Letters, July 2010, Elsevier

    Professor Keith A Wesnes

  91. Differential effects of the aromas of Salvia species on memory and mood

    Article • Human Psychopharmacology Clinical and Experimental, June 2010, Wiley

    Professor Keith A Wesnes, Dr Mark C Moss

  92. Dose-dependent changes in mood and cognitive performance following single doses of lemon balm (Melissa officinalis) to healthy young adults

    Article • Focus on Alternative and Complementary Therapies, June 2010, Wiley

    Professor Keith A Wesnes

  93. A direct comparison of the cognitive effects of acute doses of ginseng, Ginkgo biloba and their combination in healthy volunteers

    Article • Focus on Alternative and Complementary Therapies, June 2010, Wiley

    Professor Keith A Wesnes

  94. Effects of Ginkgo biloba and Panax ginseng on cognitive performance and mood in healthy young adults

    Article • Focus on Alternative and Complementary Therapies, June 2010, Wiley

    Professor Keith A Wesnes

  95. THE PROFILE OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA: IMPLICATIONS FOR THERAPEUTIC TREATMENT STRATEGIES

    Article • Schizophrenia Research, April 2010, Elsevier

    Professor Keith A Wesnes

  96. A STUDY COMPARING THE MATRICS BATTERY WITH THE CDR SYSTEM IN SHIZOPHRENIA

    Article • Schizophrenia Research, April 2010, Elsevier

    Professor Keith A Wesnes

  97. Evaluation of Dementia Rating Scales in Parkinson’s Disease Dementia

    Article • American Journal of Alzheimer s Disease & Other Dementias®, March 2010, SAGE Publications

    Professor Keith A Wesnes

  98. Subtle deficits of attention after surgery: quantifying indicators of sub syndrome delirium

    Article • International Journal of Geriatric Psychiatry, January 2010, Wiley

    Professor Keith A Wesnes

  99. Mindre inkontinens ved vektreduksjon etter fødsel

    Article • Tidsskrift for Den norske legeforening, January 2010, Norwegian Medical Association

    Professor Keith A Wesnes

  100. Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study

    Article • Mayo Clinic Proceedings, November 2009, Elsevier

    Professor Keith A Wesnes

  101. Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study

    Article • Mayo Clinic Proceedings, November 2009, Elsevier

    Professor Keith A Wesnes

  102. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg

    Article • Expert Opinion on Drug Safety, September 2009, Informa Healthcare

    Professor Keith A Wesnes

  103. The Effect of Urinary Incontinence Status During Pregnancy and Delivery Mode on Incontinence Postpartum. A Cohort Study

    Article • Obstetrical & Gynecological Survey, August 2009, Wolters Kluwer Health

    Professor Keith A Wesnes

  104. Hypertension as a treatment target for prevention of dementia: Considerations for trial design based on experience of the SCOPE and PRoFESS cognitive substudies

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  105. Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function

    Article • Human Psychopharmacology Clinical and Experimental, July 2009, Wiley

    Professor Keith A Wesnes

  106. ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  107. ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  108. Hypertension as a treatment target for prevention of dementia: Effects of candesartan on cognitive decline in older hypertensives in the SCOPE substudy, and comparison to normotensive controls

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  109. Measurement of episodic memory using word tasks in Roman and non-Roman alphabet languages: Validation from a multicentre clinical trial

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  110. Item analysis of adas-cog and cdr system cognitive measures in ad patients on stable treatment with anticholinesterases

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor Keith A Wesnes

  111. Scopolamine and the Sensory Conditioning of Hallucinations

    Article • Neuropsychobiology, June 2009, Karger Publishers

    Professor Keith A Wesnes

  112. The effect of modafinil on cognitive function in breast cancer survivors

    Article • Cancer, June 2009, Wiley

    Professor Keith A Wesnes

  113. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy

    Article • Epilepsy & Behavior, March 2009, Elsevier

    Professor Keith A Wesnes

  114. Impaired attention predicts falling in Parkinson's disease

    Article • Parkinsonism & Related Disorders, February 2009, Elsevier

    Professor Keith A Wesnes

  115. Examining the nootropic effects of a special extract ofBacopa monnieraon human cognitive functioning: 90 day double-blind placebo-controlled randomized trial

    Article • Phytotherapy Research, December 2008, Wiley

    Professor Keith A Wesnes

  116. Quantifying the association between computerised measures of attention and confusion assessment method defined delirium: a prospective study of older orthopaedic surgical patients, free of dementia

    Article • International Journal of Geriatric Psychiatry, December 2008, Wiley

    Professor Keith A Wesnes

  117. Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study

    Article • Journal of Hepatology, September 2008, Elsevier

    Professor Keith A Wesnes

  118. Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures

    Article • Perfusion, September 2008, SAGE Publications

    Professor Keith A Wesnes

  119. P4-352: The role of nicotinic receptors in human cognitive function

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  120. P4-364: Identifying cognitive enhancement in man: Showing benefits in conditions in which cognitive deficits are secondary

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  121. P4-390: Identifying cognitive enhancement in man: Models and pharmacodynamic trials in volunteers

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  122. P4-391: A computerized cognitive assessment system as an alternative to the ADAS-cog in dementia trials

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  123. P4-398: Identifying cognitive enhancement in man: Adding testing to routine phase I trials

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  124. P4-401: Identifying cognitive enhancement in man: Identifying efficacy in the dementias

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor Keith A Wesnes

  125. Candesartan and cognitive decline in older patients with hypertension: A substudy of the SCOPE trial

    Article • Neurology, May 2008, Wolters Kluwer Health

    Professor Keith A Wesnes

  126. Cognitive Performance and Morning Levels of Salivary Cortisol and α-Amylase in Children Reporting High vs. Low Daily Stress Perception

    Article • The Spanish Journal of Psychology, May 2008, Cambridge University Press

    Professor Keith A Wesnes

  127. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers

    Article • Psychopharmacology, March 2008, Springer Science + Business Media

    Professor Keith A Wesnes, Professor Andrew Scholey

  128. Assessing Change in Cognitive Function in Dementia: The Relative Utilities of the Alzheimer’s Disease Assessment Scale – Cognitive Subscale and the Cognitive Drug Research System

    Article • Neurodegenerative Diseases, March 2008, Karger Publishers

    Professor Keith A Wesnes

  129. Caffeine at levels found in decaffeinated beverages is behaviourally active

    Article • Appetite, March 2008, Elsevier

    Professor Keith A Wesnes

  130. Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study

    Article • Brain Behavior and Immunity, March 2008, Elsevier

    Professor Keith A Wesnes

  131. Effects of Smoking on Rapid Information Processing Performance

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  132. Drugs as Research Tools in Psychology: Cholinergic Drugs and Information Processing

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  133. A Comparison of Temazepam and Flurazepam in Terms of Sleep Quality and Residual Changes in Performance

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  134. Effects of Nicotine on Stimulus Sensitivity and Response Bias in a Visual Vigilance Task

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  135. Effects of Scopolamine on Stimulus Sensitivity and Response Bias in a Visual Vigilance Task

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  136. Effects of Temazepam on Sleep Quality and Subsequent Mental Efficiency under Normal Sleeping Conditions and following Delayed Sleep Onset

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Professor Keith A Wesnes

  137. The effects of l-theanine, caffeine and their combination on cognition and mood

    Article • Biological Psychology, February 2008, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  138. MODULATION OF COGNITIVE PERFORMANCE AND MOOD BY AROMAS OF PEPPERMINT AND YLANG-YLANG

    Article • International Journal of Neuroscience, January 2008, Taylor & Francis

    Professor Keith A Wesnes, Dr Mark C Moss

  139. Effects of Galantamine on Measures of Attention

    Article • Alzheimer Disease & Associated Disorders, January 2008, Wolters Kluwer Health

    Professor Keith A Wesnes

  140. A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD

    Article • Behavioral and Brain Functions, January 2008, Springer Science + Business Media

    Professor Keith A Wesnes

  141. The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls

    Article • Human Psychopharmacology Clinical and Experimental, January 2008, Wiley

    Professor Keith A Wesnes

  142. A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining throughout the morning

    Article • Appetite, July 2007, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  143. P-092

    Article • Alzheimer s & Dementia, July 2007, Elsevier

    Professor Keith A Wesnes

  144. Subtle Attentional Deficits in the Absence of Dementia Are Associated with an Increased Risk of Post-Operative Delirium

    Article • Dementia and Geriatric Cognitive Disorders, March 2007, Karger Publishers

    Professor Keith A Wesnes

  145. Dapoxetine Has No Pharmacokinetic or Cognitive Interactions With Ethanol in Healthy Male Volunteers

    Article • The Journal of Clinical Pharmacology, March 2007, Wiley

    Professor Keith A Wesnes

  146. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome

    Article • Respiratory Medicine, March 2007, Elsevier

    Professor Keith A Wesnes

  147. Neuropsychological study of underweight and “weight-recovered” anorexia nervosa compared with bulimia nervosa and normal controls

    Article • International Journal of Eating Disorders, January 2007, Wiley

    Professor Trevor Ronald Norman, Professor Keith A Wesnes

  148. An open-label study of quetiapine in anorexia nervosa

    Article • Human Psychopharmacology Clinical and Experimental, January 2007, Wiley

    Professor Trevor Ronald Norman, Professor Keith A Wesnes

  149. Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease

    Article • January 2007, Prous Science

    Professor Keith A Wesnes

  150. Effects of Donepezil on Central Processing Speed and Attentional Measures in Parkinson’s Disease with Dementia and Dementia with Lewy Bodies

    Article • Dementia and Geriatric Cognitive Disorders, December 2006, Karger Publishers

    Professor Keith A Wesnes

  151. Cognitive function testing: the case for standardization and automation

    Article • Menopause International, December 2006, SAGE Publications

    Professor Keith A Wesnes

  152. Effects of acute macronutrient ingestion on cognition and mood

    Article • Appetite, September 2006, Elsevier

    Professor Keith A Wesnes

  153. Influence of breakfast composition on children's attention and memory

    Article • Appetite, September 2006, Elsevier

    Professor Keith A Wesnes

  154. The acute behavioral effects of guaraná

    Article • Appetite, September 2006, Elsevier

    Professor Keith A Wesnes

  155. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers

    Article • Clinical Therapeutics, September 2006, Elsevier

    Professor Keith A Wesnes

  156. Behavioural improvements following acute guaraná administration

    Article • Planta Medica, August 2006, Thieme Publishing Group

    Professor Keith A Wesnes

  157. P3-204

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor Keith A Wesnes

  158. Effects of Armodafinil in the Treatment of Residual Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea Syndrome: A 12-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study in nCPAP-Adherent Adults

    Article • Clinical Therapeutics, May 2006, Elsevier

    Professor Keith A Wesnes

  159. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy

    Article • Current Medical Research and Opinion, March 2006, Informa Healthcare

    Professor Keith A Wesnes

  160. Classification of Dementia Types from Cognitive Profiles Data

    Article • January 2006, Springer Science + Business Media

    Professor Keith A Wesnes

  161. Orthostatic hypotension in Parkinson's disease: association with cognitive decline?

    Article • International Journal of Geriatric Psychiatry, January 2006, Wiley

    Professor Keith A Wesnes

  162. Expectancy and the aroma of Roman chamomile influence mood and cognition in healthy volunteers

    Article • International Journal of Aromatherapy, January 2006, Elsevier

    Professor Keith A Wesnes, Dr Mark C Moss

  163. Benefits of rivastigmine on attention in dementia associated with Parkinson disease

    Article • Neurology, November 2005, Wolters Kluwer Health

    Professor Keith A Wesnes

  164. Pharmacodynamic effects of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers

    Article • BJU International, November 2005, Wiley

    Professor Keith A Wesnes

  165. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection

    Article • AIDS, October 2005, Wolters Kluwer Health

    Professor Keith A Wesnes

  166. A10 A DOSE-RANGING STUDY OF THE COGNITIVE AND MOOD EFFECTS OF GUARAN??

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Professor Keith A Wesnes

  167. A9 COGNITIVE AND MOOD EFFECTS OF CAFFEINE AND THEANINE ALONE AND IN COMBINATION

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Professor Keith A Wesnes

  168. A26 COGNITIVE EFFECTS OF STRESS IN ANDALUCIAN CHILDREN AGED 8???12 YEARS

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Professor Keith A Wesnes

  169. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease

    Article • Current Medical Research and Opinion, August 2005, Informa Healthcare

    Professor Keith A Wesnes

  170. Computerised cognitive evaluation: 20 years of experience from the Cognitive Drug Research System

    Article • Alzheimer s & Dementia, July 2005, Elsevier

    Professor Keith A Wesnes

  171. Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans

    Article • Psychopharmacology, June 2005, Springer Science + Business Media

    Professor Keith A Wesnes

  172. An automated system for assessing cognitive function in any environment

    Article • May 2005, SPIE

    Professor Keith A Wesnes

  173. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans

    Article • The International Journal of Neuropsychopharmacology, May 2005, Oxford University Press (OUP)

    Professor Keith A Wesnes

  174. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study

    Article • Psychoneuroendocrinology, May 2005, Elsevier

    Professor Keith A Wesnes

  175. Apolipoprotein E ε4 Allele and Lorazepam Effects on Memory in High-Functioning Older Adults

    Article • Archives of General Psychiatry, February 2005, American Medical Association (AMA)

    Professor Keith A Wesnes

  176. ASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACIN

    Article • The Journal of Urology, February 2005, Elsevier

    Professor Keith A Wesnes

  177. PK/PD modeling of the interaction between IV scopolamine (SCP) and physostigmine (PHY) in healthy elderly volunteers

    Article • Clinical Pharmacology & Therapeutics, February 2005, Nature

    Professor Keith A Wesnes

  178. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine

    Article • Psychopharmacology, January 2005, Springer Science + Business Media

    Professor Keith A Wesnes, Professor Andrew Scholey

  179. The psychopharmacology of herbal extracts: issues and challenges

    Article • Psychopharmacology, January 2005, Springer Science + Business Media

    Professor Keith A Wesnes, Professor Andrew Scholey

  180. Association Between Mild Vascular Cognitive Impairment and Impaired Activities of Daily Living in Older Stroke Survivors Without Dementia

    Article • Journal of the American Geriatrics Society, January 2005, Wiley

    Professor Keith A Wesnes

  181. Effect of 902 MHz mobile phone transmission on cognitive function in children

    Article • Bioelectromagnetics, January 2005, Wiley

    Professor Keith A Wesnes

  182. Visual perception in Parkinson disease dementia and dementia with Lewy bodies

    Article • Neurology, December 2004, Wolters Kluwer Health

    Professor Keith A Wesnes

  183. Baseline Plasma GABA: Its Relationship to the Adverse Effects of Acute Lorazepam Administration on Cognition in the Elderly

    Article • Neurochemical Research, December 2004, Springer Science + Business Media

    Professor Keith A Wesnes

  184. P.6.058 Modafinil reverses the marked attentionaldeficits produced by acute sleep deprivation in healthv volunteers

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Professor Keith A Wesnes

  185. P.6.060 The memory enhancing effects of ginkgo biloba in healthy middle-aged volunteers

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Professor Keith A Wesnes

  186. Effect of Galantamine Hydrobromide in Chronic Fatigue Syndrome

    Article • JAMA, September 2004, American Medical Association (AMA)

    Professor Keith A Wesnes

  187. Effects of Acute Lorazepam Administration on Aminergic Activity in Normal Elderly Subjects: Relationship to Performance Effects and Apolipoprotein Genotype

    Article • Neurochemical Research, July 2004, Springer Science + Business Media

    Professor Keith A Wesnes

  188. Hallucinations Predict Attentional Improvements with Rivastigmine in Dementia with Lewy Bodies

    Article • Dementia and Geriatric Cognitive Disorders, June 2004, Karger Publishers

    Professor Keith A Wesnes

  189. Selective Effects of Acute Serotonin and Catecholamine Depletion on Memory in Healthy Women

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Professor Trevor Ronald Norman, Professor Keith A Wesnes

  190. Simultaneous Depletion of Serotonin and Catecholamines Impairs Sustained Attention in Healthy Female Subjects without Affecting Learning and Memory

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Professor Keith A Wesnes

  191. Natural products as cognition enhancing agents

    Article • January 2004, Springer Science + Business Media

    Professor Keith A Wesnes

  192. The effects of protective helmet use on physiology and cognition in young cricketers

    Article • Applied Cognitive Psychology, January 2004, Wiley

    Professor Keith A Wesnes, Dr Mark C Moss, Professor Andrew Scholey

  193. Breakfast reduces declines in attention and memory over the morning in schoolchildren

    Article • Appetite, December 2003, Elsevier

    Professor Keith A Wesnes

  194. Reliable diagnoses of dementia by the naive credal classifier inferred from incomplete cognitive data

    Article • Artificial Intelligence in Medicine, September 2003, Elsevier

    Professor Keith A Wesnes

  195. Increased Anticholinergic Challenge-Induced Memory Impairment Associated with the APOE-ɛ4 Allele in the Elderly: A Controlled Pilot Study

    Article • Neuropsychopharmacology, August 2003, Nature

    Professor Keith A Wesnes

  196. Mild Cognitive Impairment and Vascular Cognitive Impairment in Stroke Patients

    Article • International Psychogeriatrics, July 2003, Cambridge University Press

    Professor Keith A Wesnes

  197. Erratum to “Chewing gum selectively improves aspects of memory in healthy volunteers [Appetite 38 (2002) 235–236]”

    Article • Appetite, June 2003, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  198. Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers

    Article • Pharmacology Biochemistry and Behavior, June 2003, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  199. Regulation of attention and response to therapy in dementia by butyrylcholinesterase

    Article • Pharmacogenetics, April 2003, Wolters Kluwer Health

    Professor Keith A Wesnes, Dr Christopher M Morris

  200. AROMAS OF ROSEMARY AND LAVENDER ESSENTIAL OILS DIFFERENTIALLY AFFECT COGNITION AND MOOD IN HEALTHY ADULTS

    Article • International Journal of Neuroscience, January 2003, Taylor & Francis

    Professor Keith A Wesnes, Dr Mark C Moss

  201. Effects of Hypertension on Attention, Memory, and Executive Function in Older Adults.

    Article • Health Psychology, January 2003, American Psychological Association (APA)

    Professor Keith A Wesnes

  202. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients

    Article • International Clinical Psychopharmacology, January 2003, Wolters Kluwer Health

    Professor Keith A Wesnes

  203. The brain effects of occupational strength 50 Hz magnetic field

    Article • January 2003, Institute of Electrical & Electronics Engineers (IEEE)

    Professor Keith A Wesnes

  204. Practice effects on cognitive tasks: a major problem?

    Article • The Lancet Neurology, December 2002, Elsevier

    Professor Keith A Wesnes

  205. Neuropsychological Deficits in Older Stroke Patients

    Article • Annals of the New York Academy of Sciences, November 2002, Wiley

    Professor Keith A Wesnes

  206. Cognitive Associations of Subcortical White Matter Lesions in Older People

    Article • Annals of the New York Academy of Sciences, November 2002, Wiley

    Professor Keith A Wesnes

  207. Reboxetine effects on cognitive functioning in depressed patients

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Professor Keith A Wesnes

  208. Predicting response to rivastigmine in dementia with Lewy Bodies

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Professor Keith A Wesnes

  209. The effects of a combination of ginseng, vitamins and minerals on cognitive and physical fatigue induced by night-work in nurses

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Professor Keith A Wesnes

  210. Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers

    Article • Neuropsychopharmacology, July 2002, Nature

    Professor Keith A Wesnes

  211. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)

    Article • Pharmacology Biochemistry and Behavior, July 2002, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  212. Chewing gum selectively improves aspects of memory in healthy volunteers

    Article • Appetite, June 2002, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  213. The effect of glucose administration and the emotional content of words on heart rate and memory

    Article • Journal of Psychopharmacology, May 2002, SAGE Publications

    Professor Keith A Wesnes

  214. Apolipoprotein E  4 and short-term recovery from predominantly mild brain injury

    Article • Neurology, April 2002, Wolters Kluwer Health

    Professor Keith A Wesnes

  215. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults

    Article • Physiology & Behavior, April 2002, Elsevier

    Professor Keith A Wesnes, Professor Andrew Scholey

  216. Basal activity of the HPA axis and cognitive function in anorexia nervosa

    Article • The International Journal of Neuropsychopharmacology, March 2002, Oxford University Press (OUP)

    Professor Keith A Wesnes

  217. Assessing cognitive function in clinical trials: latest developments and future directions

    Article • Drug Discovery Today, January 2002, Elsevier

    Professor Keith A Wesnes

  218. The acute effects of combined administration ofGinkgo biloba andBacopa monniera on cognitive function in humans

    Article • Human Psychopharmacology Clinical and Experimental, January 2002, Wiley

    Professor Keith A Wesnes

  219. The acute nootropic effects ofGinkgo biloba in healthy older human subjects: a preliminary investigation

    Article • Human Psychopharmacology Clinical and Experimental, January 2002, Wiley

    Professor Keith A Wesnes

  220. Water ingestion improves subjective alertness, but has no effect on cognitive performance in dehydrated healthy young volunteers

    Article • Appetite, December 2001, Elsevier

    Professor Keith A Wesnes, Dr Mark C Moss, Professor Andrew Scholey

  221. The use of cognitive tests to facilitate drug and dose selection in Phase I and to optimise dosing in Phase IV

    Article • International Congress Series, August 2001, Elsevier

    Professor Keith A Wesnes

  222. Credal Classification for Dementia Screening

    Article • January 2001, Springer Science + Business Media

    Professor Keith A Wesnes

  223. Reboxetine effects on cognitive functioning in depressed patients

    Article • European Neuropsychopharmacology, January 2001, Elsevier

    Professor Keith A Wesnes

  224. Differential, Dose Dependent Changes in Cognitive Performance Following Acute Administration of aGinkgo biloba/Panax ginsengCombination to Healthy Young Volunteers

    Article • Nutritional Neuroscience, January 2001, Taylor & Francis

    Professor Keith A Wesnes

  225. Dose Dependent Changes in Cognitive Performance and Mood following Acute Administration ofGinsengto Healthy Young Volunteers

    Article • Nutritional Neuroscience, January 2001, Taylor & Francis

    Professor Keith A Wesnes

  226. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

    Article • The Lancet, December 2000, Elsevier

    Professor Keith A Wesnes

  227. Cognitive Performance in Hypertensive and Normotensive Older Subjects

    Article • Hypertension, December 2000, Wolters Kluwer Health

    Professor Keith A Wesnes

  228. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

    Article • Psychopharmacology, November 2000, Springer Science + Business Media

    Professor Keith A Wesnes

  229. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers

    Article • Psychopharmacology, September 2000, Springer Science + Business Media

    Professor Keith A Wesnes, Professor Andrew Scholey

  230. What are the optimal tests for determining enhanced cognitive function in humans?

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Professor Keith A Wesnes

  231. A Ginkgo biloba/Panax ginseng combination enhances memory in healthy middle aged volunteers

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Professor Keith A Wesnes

  232. Dose-dependent enhancement of cognitive performance in young volunteers following single doses of Ginkgo biloba

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Professor Keith A Wesnes

  233. A comparison of the effects on cognitive function of E-5842 administered as a single or multiple dose

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Professor Keith A Wesnes

  234. Dose-dependent enhancement of cognitive performance in young volunteers by a single doses of Ginseng

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Professor Keith A Wesnes

  235. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

    Article • Neurology, April 2000, Wolters Kluwer Health

    Professor Keith A Wesnes

  236. 537. White matter fractional anisotropy and lorazepam-induced cognitive toxicity in the elderly

    Article • Biological Psychiatry, April 2000, Elsevier

    Professor Keith A Wesnes

  237. Neuropsychologic dysfunction after CABG: standard cardiopulmonary bypass versus off-pump CABG

    Article • Critical Care, March 2000, Springer Science + Business Media

    Professor Keith A Wesnes

  238. PLANT ENGINEERING MAINTENANCE SERIES

    Article • January 2000, Elsevier

    Professor Keith A Wesnes

  239. Cognitive Performance, Hyperoxia, and Heart Rate Following Oxygen Administration in Healthy Young Adults

    Article • Physiology & Behavior, November 1999, Elsevier

    Professor Keith A Wesnes, Dr Mark C Moss, Professor Andrew Scholey

  240. Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage

    Article • European Neuropsychopharmacology, September 1999, Elsevier

    Professor Keith A Wesnes

  241. Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development

    Article • European Neuropsychopharmacology, September 1999, Elsevier

    Professor Keith A Wesnes

  242. Aetiology of Cognitive Deficits following Cabg

    Article • Clinical Science, July 1999, Portland Press Ltd.

    Professor Keith A Wesnes

  243. A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease

    Article • Human Psychopharmacology Clinical and Experimental, June 1999, Wiley

    Professor Keith A Wesnes

  244. Central (CE) vs. Peripheral (PE) effects of I.V. bolus scopolamine (SCP) in healthy young and elderly females*

    Article • Clinical Pharmacology & Therapeutics, February 1999, Nature

    Professor Keith A Wesnes

  245. Relationships among age, conditioned stimulus–unconditioned stimulus interval, and neuropsychological test performance.

    Article • Neuropsychology, January 1999, American Psychological Association (APA)

    Professor Keith A Wesnes

  246. Relationships among age, conditioned stimulus-unconditioned stimulus interval, and neuropsychological test performance.

    Article • Neuropsychology, January 1999, American Psychological Association (APA)

    Professor Keith A Wesnes

  247. Oxygen and cognitive performance: the temporal relationship between hyperoxia and enhanced memory

    Article • Psychopharmacology, November 1998, Springer Science + Business Media

    Professor Keith A Wesnes, Dr Mark C Moss, Professor Andrew Scholey

  248. Effects of low doses of amisulpride on psychomotor and memory performances in healthy elderly subjects

    Article • European Neuropsychopharmacology, November 1998, Elsevier

    Professor Keith A Wesnes

  249. Pharmacokinetics and Pharmacodynamics of Scopolamine after Subcutaneous Administration

    Article • The Journal of Clinical Pharmacology, August 1998, Wiley

    Professor Keith A Wesnes

  250. Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebo-controlled double-blind crossover study

    Article • Psychopharmacology, July 1998, Springer Science + Business Media

    Professor Keith A Wesnes, Dr Mark C Moss, Professor Andrew Scholey

  251. Effects of physostigmine on scopolamine–induced changes in quantitative electroencephalogram and cognitive performance

    Article • Human Psychopharmacology Clinical and Experimental, April 1998, Wiley

    Professor Keith A Wesnes

  252. Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance

    Article • Human Psychopharmacology Clinical and Experimental, April 1998, Wiley

    Professor Keith A Wesnes

  253. Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers: a 6-year follow-up

    Article • International Journal of Geriatric Psychiatry, April 1998, Wiley

    Professor Keith A Wesnes

  254. Validity of a cognitive computerized assessment system in brain injured patients

    Article • Brain Injury, January 1998, Taylor & Francis

    Professor Keith A Wesnes

  255. Tiagabine: Absence of Kinetic or Dynamic Interactions with Ethanol

    Article • Drug Metabolism and Drug Interactions, January 1998, De Gruyter

    Professor Keith A Wesnes

  256. Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits

    Article • Journal of Psychopharmacology, January 1998, SAGE Publications

    Professor Keith A Wesnes

  257. The effect of a 50 Hz magnetic field on cognitive function in humans

    Article • International Journal of Radiation Biology, January 1998, Taylor & Francis

    Professor Keith A Wesnes

  258. Moxonidine and cognitive function: interactions with moclobemide and lorazepam

    Article • European Journal of Clinical Pharmacology, August 1997, Springer Science + Business Media

    Professor Keith A Wesnes

  259. BRIDGING STUDY OF S12024 IN 53 IN-PATIENTS WITH ALZHEIMER'S DISEASE

    Article • Journal of the American Geriatrics Society, January 1997, Wiley

    Professor Keith A Wesnes

  260. Cholinergic therapy directed at cognitive deficits

    Article • European Neuropsychopharmacology, June 1996, Elsevier

    Professor Keith A Wesnes

  261. Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men*

    Article • Clinical Pharmacology & Therapeutics, June 1996, Nature

    Professor Keith A Wesnes

  262. Flesinoxan improves cognition in the healthy elderly

    Article • European Neuropsychopharmacology, June 1996, Elsevier

    Professor Keith A Wesnes

  263. Cognitive performance and mood changes over 24 hours of smoking abstinence

    Article • European Neuropsychopharmacology, June 1996, Elsevier

    Professor Keith A Wesnes

  264. No kinetic or dynamic interaction between flesinoxan and fluoxetine

    Article • European Neuropsychopharmacology, June 1996, Elsevier

    Professor Keith A Wesnes

  265. The effect of olanzapine on cognition and psychomotor function in healthy elderly volunteers

    Article • Schizophrenia Research, February 1996, Elsevier

    Professor Keith A Wesnes

  266. 205 Psychological function in dementia with lewy bodies and senile dementia of Alzheimer's type

    Article • Neurobiology of Aging, January 1996, Elsevier

    Professor Keith A Wesnes

  267. Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers

    Article • International Journal of Geriatric Psychiatry, December 1995, Wiley

    Professor Keith A Wesnes

  268. The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence?

    Article • International Journal of Geriatric Psychiatry, March 1995, Wiley

    Professor Keith A Wesnes

  269. Cognitive and Quantified Electroencephalographic Correlates of Cycloserine Treatment in Alzheimerʼs Disease

    Article • Clinical Neuropharmacology, February 1995, Wolters Kluwer Health

    Professor Keith A Wesnes

  270. Single dose human pharmacology of umespirone

    Article • European Journal of Clinical Pharmacology, June 1994, Springer Science + Business Media

    Professor Keith A Wesnes

  271. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function

    Article • Clinical Pharmacology & Therapeutics, October 1992, Nature

    Professor Keith A Wesnes

  272. Automated microcomputerized cognitive evaluation of the elderly and demented: utility, validity, relevance to everyday behaviour and drug sensitivity

    Article • European Neuropsychopharmacology, September 1992, Elsevier

    Professor Keith A Wesnes

  273. Influence of multiple-dose administration of fluvoxamine on the pharmacokinetics of the benzodiazepinen bromazepam and lorazepam: a randomised, cross-over study

    Article • European Neuropsychopharmacology, September 1992, Elsevier

    Professor Keith A Wesnes

  274. Smoking, Nicotine and Human Performance

    Article • January 1992, Elsevier

    Professor Keith A Wesnes

  275. AUTOMATED MICROCOMPUTERIZED COGNITIVE EVALUATION OF THE ELDERLY AND DEMENTED

    Article • Clinical Neuropharmacology, January 1992, Wolters Kluwer Health

    Professor Keith A Wesnes

  276. THE UTILITY, VALIDITY AND PREDICTABILITY OF THE SCOPOLAMINE MODEL OF DEMENTIA

    Article • Clinical Neuropharmacology, January 1992, Wolters Kluwer Health

    Professor Keith A Wesnes

  277. Effects of NMDA Modulation in Scopolamine Dementiaa

    Article • Annals of the New York Academy of Sciences, December 1991, Wiley

    Professor Keith A Wesnes

  278. Cholinesterase Inhibition in the Scopolamine Model of Dementia

    Article • Annals of the New York Academy of Sciences, December 1991, Wiley

    Professor Keith A Wesnes

  279. The cognitive drug research computerized assessment system for demented patients: A validation study

    Article • International Journal of Geriatric Psychiatry, February 1991, Wiley

    Professor Keith A Wesnes

  280. Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia

    Article • Acta Psychiatrica Scandinavica, September 1990, Wiley

    Professor Keith A Wesnes

  281. Group Report 3: Early Clinical Testing of Cognition Enhancers: Prediction of Efficacy

    Article • Pharmacopsychiatry, February 1990, Thieme Publishing Group

    Professor Keith A Wesnes

  282. EFFECTS OF TEMAZEPAM PREMEDICATION ON COGNITIVE RECOVERY FOLLOWING ALFENTANIL—PROPOFOL ANAESTHESIA

    Article • British Journal of Anaesthesia, January 1989, Oxford University Press (OUP)

    Professor Keith A Wesnes

  283. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects

    Article • Psychopharmacology, August 1987, Springer Science + Business Media

    Professor Keith A Wesnes

  284. Nicotine Increases Mental Efficiency: But How?

    Article • January 1987, Springer Science + Business Media

    Professor Keith A Wesnes

  285. Facilitation of learning and state dependency with nicotine

    Article • Psychopharmacology, May 1986, Springer Science + Business Media

    Professor Keith A Wesnes

  286. Evidence of more rapid stimulus evaluation following cigarette smoking

    Article • Addictive Behaviors, January 1985, Elsevier

    Professor Keith A Wesnes

  287. Acetylcholine and Attentional Disorder

    Article • January 1985, Springer Science + Business Media

    Professor Keith A Wesnes

  288. Historical Overview of Research on Cholinergic Systems and Behavior

    Article • January 1985, Springer Science + Business Media

    Professor Keith A Wesnes

  289. Smoking as a coping strategy

    Article • Addictive Behaviors, January 1985, Elsevier

    Professor Keith A Wesnes

  290. Smoking and academic performance

    Article • Current Psychology, September 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  291. The separate and combined effects of scopolamine and nicotine on human information processing

    Article • Psychopharmacology, September 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  292. The effects of cigarettes of varying yield on rapid information processing performance

    Article • Psychopharmacology, March 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  293. Effects of scopolamine and nicotine on human rapid information processing performance

    Article • Psychopharmacology, January 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  294. Work and Stress as Motives for Smoking

    Article • January 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  295. Nicotine and the Control of Smoking Behaviour

    Article • January 1984, Springer Science + Business Media

    Professor Keith A Wesnes

  296. Smoking, nicotine and human performance

    Article • Pharmacology & Therapeutics, January 1983, Elsevier

    Professor Keith A Wesnes

  297. The effects of psychoactive drugs on human behaviour

    Article • American Psychological Association (APA)

    Professor Keith A Wesnes

  298. The Effects of Psychotropic Drugs upon Human Behaviour

    Article • Karger Publishers

    Professor Keith A Wesnes